Refine
Has Fulltext
- yes (118)
Is part of the Bibliography
- yes (118)
Year of publication
Document Type
- Journal article (118) (remove)
Language
- English (118) (remove)
Keywords
- Neisseria meningitidis (13)
- Echinococcus (6)
- Tanzania (6)
- meningococcal disease (6)
- Aspergillus (4)
- Germany (4)
- antimicrobial resistance (4)
- neisseria meningitidis (4)
- stem cells (4)
- COVID-19 (3)
- MRSA (3)
- Meningitis (3)
- SARS-CoV-2 (3)
- infection (3)
- inflammation (3)
- meningitis (3)
- multilocularis (3)
- ARONJ (2)
- Apoptosis (2)
- BDG (2)
- C5aR1 (2)
- Candida auris (2)
- Echinococcosis (2)
- Fusarium (2)
- Group B Streptococcus (2)
- HBMEC (2)
- Haemophilus influenzae (2)
- Neisseria gonorrhoeae (2)
- Rhizopus (2)
- Stem cell (2)
- Ureaplasma parvum (2)
- Ureaplasma urealyticum (2)
- alveolar echinococcosis (2)
- antigen (2)
- antimicrobial stewardship (2)
- bacteria (2)
- bacterial meningitis (2)
- bacterial pathogens (2)
- beta-D-glucan (2)
- blood–brain barrier (2)
- brain endothelial cells (2)
- candidemia (2)
- colonization (2)
- comparative genomics (2)
- diagnosis (2)
- echinococcus multilocularis (2)
- galactomannan (2)
- gene conversion (2)
- gene expression (2)
- genome sequencing (2)
- granulocytes (2)
- haemophilus influenzae (2)
- homologous recombination (2)
- infection control (2)
- men who have sex with men (2)
- microbiology (2)
- neuroinflammation (2)
- neutrophils (2)
- osteonecrosis of the jaw (2)
- osteoradionecrosis (2)
- outer membrane protein (2)
- pathogens (2)
- platyhelminthes (2)
- sepsis (2)
- sphingolipids (2)
- surgical site infection (2)
- transcriptome (2)
- 5-methyl cytosine (1)
- Acetylated tubulin (1)
- Alkaline phosphatase (1)
- Alternaria (1)
- Argonaute (1)
- Ascaris lumbricoides (1)
- Aspergillus fumigatus (1)
- AurisID (1)
- B neisseria meningitidis (1)
- BacT/ALERT (1)
- Bacterial meningitis (1)
- Benzimidazoles (1)
- Biohazard (1)
- Brain endothelial cells (1)
- Brugia Malayi (1)
- C-reactive protein (1)
- C3a (1)
- C3aR (1)
- C5a (1)
- C5aR2 (1)
- CCL3 (1)
- CCL4 (1)
- CCL5 (1)
- COVID-19 testing (1)
- COVID‐19 (1)
- CPG binding domain (1)
- Calibration (1)
- Cancer treatment (1)
- Candida albicans (1)
- Candida lusitaniae (1)
- Caspase (1)
- Ceramide (1)
- Cestoda (1)
- Cestoda Taeniidae (1)
- Cestode (1)
- Chagas disease (1)
- Circinella (1)
- Clinical prediction rule (1)
- Colombia (1)
- Colonization (1)
- Community-acquired methicillin-resistant Staphylococcus aureus (1)
- DNA methylation (1)
- DNA recombination (1)
- Densovirus (1)
- Disaster response (1)
- ESBL (1)
- Efflux transport (1)
- Elderly (1)
- Emergence (1)
- Enterobacteriaceae (1)
- Epigenetic (1)
- Escherichia coli K1 (1)
- Escherichia coli infections (1)
- Europe (1)
- Expansion microscopy (1)
- False positive reactions (1)
- FinO family (1)
- Fks1 (1)
- FoxQ2 (1)
- Fungiplex Candida Auris (1)
- GM (1)
- Gene silencing (1)
- Geriatric care (1)
- Geriatrics (1)
- Germinative cell (1)
- Golgi (1)
- HFQ (1)
- HIV (1)
- Hospital emergency plan (1)
- Host-parasite interaction (1)
- Host-pathogen interactions (1)
- I-lactate (1)
- IA (1)
- ICM (1)
- IDSA (1)
- IMD (1)
- IctP (1)
- Inducible Clindamycin Resistance (1)
- Infection control (1)
- Insulin (1)
- Jurkat cells (1)
- Kinase inhibitor (1)
- LTR retrotransposons (1)
- Larvae (1)
- Lichtheimia (1)
- Listeria monocytogenes (1)
- MITE (1)
- MLST (1)
- MRONJ (1)
- MSIS (1)
- Mass critical care (1)
- Medicine (1)
- Medizin (1)
- Meningococcal infection (1)
- Meningococcal polysaccharide caccine (1)
- Meningococcal serogroup C (1)
- Meningococci (1)
- Mesocestoides corti (1)
- Metacestode (1)
- Methicillin resistant Staphylococcus aureus (1)
- Methicillin-resistant Staphylococcus aureus (1)
- Methicillin-resistant staphylococcus aureus (1)
- Mikrobiologie (1)
- Mobile genetic element (1)
- Mucin (1)
- Mucor (1)
- Mucorales (1)
- Multiplex PCR (1)
- Mwanza (1)
- Mycobacterium marinum (1)
- N-oleoyl serinol (1)
- NAS (1)
- Nanos (1)
- Nasal Carriage (1)
- Neisseria (1)
- Neoblast (1)
- Nervous system (1)
- Neuroinfectiology (1)
- Neuroinflammation (1)
- Neuropeptide (1)
- Nursing homes (1)
- ONJ (1)
- One Health (1)
- P-glycoprotein (1)
- P-gp (1)
- P. aeruginosa (1)
- PMNs (1)
- Parvovirus (1)
- Pathogens (1)
- Pentastomiasis (1)
- Pneumococci (1)
- Predictive value of tests (1)
- Prevalence (1)
- Protoscolex (1)
- Purpureocillium (1)
- RNA (1)
- RNA chaperone Hfq (1)
- Receptor kinase (1)
- Rhizomucor (1)
- S. aureus (1)
- SARS‐CoV‐2 (1)
- SFRP (1)
- ST 772 (1)
- ST1797 (1)
- ST88 (1)
- Scedosporium (1)
- Schistosoma mansoni (1)
- Sequence motif analysis (1)
- Serotonin (1)
- Sierra Nevada (1)
- Six3/6 Wnt (1)
- Skin (1)
- Staphylococcus aureus (1)
- Stem cells (1)
- Streptococcus agalactiae (1)
- Streptococcus suis (1)
- Surgery (1)
- T Cells (1)
- T cells (1)
- TGF-BETA (1)
- TNF-alpha (1)
- Tapeworm (1)
- Tropheryma whipplei (1)
- Tuberculosis (1)
- Ureaplasma (1)
- Ureaplasma species (1)
- Vaccination (1)
- Valentine Leukocidin Genes (1)
- Vesicles (1)
- WBC (1)
- Whipple's disease (1)
- Xenopus oocytes (1)
- acute watery diarrhea (1)
- admission screening (1)
- agar (1)
- agar diffusion test (1)
- alloSCT patients (1)
- alternative pig farming (1)
- alveoar echinococcosis (1)
- ampicillin (1)
- anaphylatoxins (1)
- anidulafungin (1)
- antero-posterior axis (1)
- antibiotic bone concentration (1)
- antibiotic prescription behavior (1)
- antibiotic use (1)
- antibodies (1)
- anticoagulants (1)
- antifungal susceptibility (1)
- antifungals (1)
- antigen testing (1)
- antigen-B (1)
- antigens (1)
- antimicrobial responses (1)
- antimicrobials (1)
- antiresorptive drug-related osteonecrosis of the jaw (1)
- anxiety (1)
- assay (1)
- attitude of health personnel (1)
- atypical chemokine receptor 3 (1)
- aureus infections (1)
- autochthonous infection (1)
- azole resistance (1)
- bactericidal activity (1)
- benzimidazole (1)
- beta-lactam (1)
- beta-tubulin (1)
- beta‐d‐glucan (1)
- biological techniques (1)
- biomarker (1)
- biosynthesis (1)
- blood (1)
- blood fluke (1)
- blood stream infections (1)
- blood-brain barrier (1)
- blood-cerebrospinal fluid barrier (1)
- bloodstream infection (1)
- brain barrier (1)
- brain endothelial cell (1)
- breakthrough (1)
- bronchoalveolar lavage fluid (1)
- campylobacteriosis (1)
- cardiovascular MRI (1)
- caspase-3 (1)
- caspofungin (1)
- cell staining (1)
- cell wall (1)
- cells (1)
- central-nervous-system (1)
- cephalosporin-resistant gram-negative bacteria (1)
- ceramide (1)
- ceramide analogs (1)
- cestodes (1)
- chaperone (1)
- chemical properties (1)
- chemotherapy (1)
- children (1)
- chorioamnionitis (1)
- choroid-plexus (1)
- circulating (1)
- coagulase-negative staphylococci (1)
- commercial kits (1)
- community settings (1)
- complement system (1)
- complex (1)
- cord blood (1)
- corticosteroids (1)
- cryptic (1)
- cutibacteria (1)
- cytokines (1)
- dRNA-seq (1)
- dendritic cells (1)
- depression (1)
- detection limits (1)
- differential age distribution (1)
- digital phenotyping (1)
- disease-associated (1)
- dual function (1)
- echinocandin (1)
- echinocandins (1)
- echinococcosis (1)
- ecological momentary assessment (1)
- ecology (1)
- efflux pumps (1)
- elucidation (1)
- endophthalmitis (1)
- endothelial cells (1)
- epgenetics (1)
- epidemiology (1)
- epidermal growth factor (1)
- epithelial cells (1)
- excretory-secretory (1)
- expert recommendation (1)
- extracellular (1)
- eye infection (1)
- factor H (1)
- feasibility study (1)
- field gel-electrophoreresis (1)
- flatworm (1)
- flow cytometry (1)
- fluorescence microscopy (1)
- fungal antigens (1)
- fungal infection (1)
- fungal molecular diagnostics (1)
- fungi (1)
- fungicidal activity (1)
- galectin-2 (1)
- gangliosides and lipid rafts (1)
- gen (1)
- gene (1)
- general practice (1)
- general practitioner (1)
- generalized anxiety disorder (1)
- genetic loci (1)
- genetic variation (1)
- genetics (1)
- genome (1)
- genomic databases (1)
- genomic libraries (1)
- germinative cells (1)
- glucan synthase (1)
- glutamate dehydrogenase (1)
- glutathione (1)
- granulosus (1)
- group-B (1)
- heart (1)
- hematopoietic stem cell transplantation (1)
- hemihepatectomy (1)
- hospital-acquired methicillin-resistant Staphylococcus aureus (1)
- host defense (1)
- host response (1)
- host-pathogen interaction (1)
- host-pathogen interactions (1)
- host–pathogen interaction (1)
- human behaviour (1)
- human brain microvascular endothelial cells (1)
- hydatid disease (1)
- hydrogels (1)
- hyphae (1)
- identification (1)
- imaging (1)
- immune evasion (1)
- immune impairment (1)
- immune response (1)
- immunogenetics (1)
- immunology (1)
- immunomodulation (1)
- immunoprecipitation (1)
- immunotherapy (1)
- in vitro (1)
- in vivo (1)
- indigenous (1)
- induced pluripotent stem cells (1)
- infection prevention (1)
- infectious diseases management (1)
- innate immune evasions (1)
- innate immune response (1)
- interstage aspiration (1)
- intervention strategies (1)
- intravenous ceftriaxone (1)
- intravitreal vancomycin and amikacin (1)
- invasive aspergillosis (1)
- invasive disease (1)
- invasive meningococcal disease (1)
- invasive pulmonary aspergillosis (1)
- jaw bone (1)
- joint aspiration (1)
- joint infection (1)
- keratitis (1)
- killing (1)
- knowledge (1)
- laboratory techniques and procedures (1)
- large animal models (1)
- larvae (1)
- leptomeningeal cells (1)
- leucocyte count (1)
- liver (1)
- liver resection (1)
- livestock-associated staphylococci (1)
- long noncoding RNA (1)
- longitudinal studies (1)
- mammalian genomics (1)
- mannan (1)
- marker (1)
- matrix metallopeptidase-1 (1)
- maximum liklihood (1)
- mebendazole (1)
- meningeal blood-csf barrier (1)
- meningococcal lineages (1)
- meningococcal polysaccharides (1)
- meningococcus (1)
- metabolism (1)
- metacestode vesicles (1)
- metamorphosis (1)
- methyltransferase homolog (1)
- micafungin (1)
- mice (1)
- microRNA (1)
- microbial surface component recognising adhesive matrix molecules (1)
- microbiological culture (1)
- microbiology techniques (1)
- microscopy (1)
- microvascular endothelial cells (1)
- microvascular endothelial-cells (1)
- mitochondria (1)
- mitochondrial dynamics (1)
- mitochondrial morphology (1)
- mobile crowdsensing (1)
- mobile health (1)
- molecular characterization (1)
- molecular epidemiology (1)
- monoclonal antibody (1)
- monocytes (1)
- mouse model (1)
- mouse models (1)
- multifaceted approaches (1)
- multiple myeloma (1)
- mycobacterial infection (1)
- mycophenolic acid (1)
- myocyte (1)
- natamycin (1)
- natural killer cell (1)
- natural transformation (1)
- neglected groups (1)
- neoblast (1)
- neonatal morbidity (1)
- nitrite respiration (1)
- nitrites (1)
- non-aureus staphylococci (1)
- nonautonomous (1)
- nosocomial transmission (1)
- nuclear magnetic resonance (1)
- ocular infection (1)
- one-health approach (1)
- oral cefpodoxime (1)
- oral doxycycline (1)
- oral microbiome (1)
- organic farming (1)
- organoid (1)
- outpatient (1)
- oxidative stress (1)
- panton-valentine leukocidin (1)
- paradoxical effect (1)
- paradoxical growth (1)
- parasitic diseases (1)
- pathometabolism (1)
- pediatric (1)
- pediatrician (1)
- periprosthetic joint infection (1)
- phase variation (1)
- phylotypic (1)
- pig (1)
- pig farming methods (1)
- piperacillin (1)
- piperacillin/tazobactam (1)
- planarian (1)
- plexus epithelial-cells (1)
- pluripotency (1)
- polymorphonuclear neutrophils (1)
- population biology (1)
- population genetics (1)
- post-operative antibiotic treatment (1)
- primary care (1)
- primary cells (1)
- probe-based real-time PCR (1)
- protein kinases (1)
- proteins (1)
- proteomic analysis (1)
- public health (1)
- qPCR (1)
- quality of life (1)
- real-time PCR (1)
- recombinant proteins (1)
- regulator (1)
- regulatory T cells (1)
- relA (1)
- research infrastructure (1)
- resistance (1)
- retrotransposition (1)
- revision arthroplasty (1)
- schistoma mansoni (1)
- sensitivity (1)
- sensitivity and specificity (1)
- septic (1)
- sequence (1)
- sequence assembly tools (1)
- serogroup B (1)
- serogroup-Y (1)
- serology (1)
- seroprevalence (1)
- serum (1)
- single-molecule tracking (1)
- sirolimus (1)
- small RNA (1)
- small interfering RNAs (1)
- spa typing (1)
- sporidia (1)
- state-based model (1)
- stem cell transplantation (1)
- strain MC58 (1)
- strain specificity (1)
- stringent response (1)
- structural determination (1)
- super-resolution microscopy (1)
- surgical intra-abdominal infections (1)
- survey (1)
- systems biology (1)
- tapeworm (1)
- taxonomy (1)
- tazobactam (1)
- testing strategy (1)
- therapy (1)
- throat (1)
- tight junctions (1)
- topic ofloxacin (1)
- transcription factors (1)
- translational research (1)
- transplantation (1)
- transposable elements (1)
- ultrahigh-field MRI (1)
- under five children (1)
- upper extremity (1)
- utilization (1)
- vaccine development (1)
- vaccines (1)
- vesicles (1)
- viral load (1)
- virulence (1)
- virulenceregulatory evolution (1)
- vitrectomy (1)
- water microbiology (1)
- white blood cell count (1)
- whole blood ex vivo model (1)
- whole-blood infection assay (1)
- whole-blood model (1)
- zinc cluster transcription factor (1)
- γ-glutamyl cycle (1)
Institute
- Institut für Hygiene und Mikrobiologie (118) (remove)
Sonstige beteiligte Institutionen
- Department of Hematology and Oncology, Sana Hospital Hof, Hof, Germany (1)
- Department of Laboratory Medicine and Medicine Huddinge, Karolinska Institutet and University Hospital, Stockholm, Sweden (1)
- Department of Medicine A, University Hospital of Münster, Münster, Germany (1)
- Krankenhaushygiene und Antimicrobial Stewardship (1)
- Krankenhaushygiene und Antimicrobial Stewardship (Universitätsklinikum) (1)
- Research Center for Infectious Diseases (ZINF), University of Würzburg, Würzburg, Germany (1)
EU-Project number / Contract (GA) number
- 2016 FGR 0053 (1)
- 278864 (1)
- 847507 (1)
Ultra-high field cardiac MRI in large animals and humans for translational cardiovascular research
(2023)
A key step in translational cardiovascular research is the use of large animal models to better understand normal and abnormal physiology, to test drugs or interventions, or to perform studies which would be considered unethical in human subjects. Ultrahigh field magnetic resonance imaging (UHF-MRI) at 7 T field strength is becoming increasingly available for imaging of the heart and, when compared to clinically established field strengths, promises better image quality and image information content, more precise functional analysis, potentially new image contrasts, and as all in-vivo imaging techniques, a reduction of the number of animals per study because of the possibility to scan every animal repeatedly. We present here a solution to the dual use problem of whole-body UHF-MRI systems, which are typically installed in clinical environments, to both UHF-MRI in large animals and humans. Moreover, we provide evidence that in such a research infrastructure UHF-MRI, and ideally combined with a standard small-bore UHF-MRI system, can contribute to a variety of spatial scales in translational cardiovascular research: from cardiac organoids, Zebra fish and rodent hearts to large animal models such as pigs and humans. We present pilot data from serial CINE, late gadolinium enhancement, and susceptibility weighted UHF-MRI in a myocardial infarction model over eight weeks. In 14 pigs which were delivered from a breeding facility in a national SARS-CoV-2 hotspot, we found no infection in the incoming pigs. Human scanning using CINE and phase contrast flow measurements provided good image quality of the left and right ventricle. Agreement of functional analysis between CINE and phase contrast MRI was excellent. MRI in arrested hearts or excised vascular tissue for MRI-based histologic imaging, structural imaging of myofiber and vascular smooth muscle cell architecture using high-resolution diffusion tensor imaging, and UHF-MRI for monitoring free radicals as a surrogate for MRI of reactive oxygen species in studies of oxidative stress are demonstrated. We conclude that UHF-MRI has the potential to become an important precision imaging modality in translational cardiovascular research.
Psychosocial factors affect mental health and health-related quality of life (HRQL) in a complex manner, yet gender differences in these interactions remain poorly understood. We investigated whether psychosocial factors such as social support and personal and work-related concerns impact mental health and HRQL differentially in women and men during the first year of the COVID-19 pandemic. Between June and October 2020, the first part of a COVID-19-specific program was conducted within the “Characteristics and Course of Heart Failure Stages A-B and Determinants of Progression (STAAB)” cohort study, a representative age- and gender-stratified sample of the general population of Würzburg, Germany. Using psychometric networks, we first established the complex relations between personal social support, personal and work-related concerns, and their interactions with anxiety, depression, and HRQL. Second, we tested for gender differences by comparing expected influence, edge weight differences, and stability of the networks. The network comparison revealed a significant difference in the overall network structure. The male (N = 1370) but not the female network (N = 1520) showed a positive link between work-related concern and anxiety. In both networks, anxiety was the most central variable. These findings provide further evidence that the complex interplay of psychosocial factors with mental health and HRQL decisively depends on gender. Our results are relevant for the development of gender-specific interventions to increase resilience in times of pandemic crisis.
Pathogen-specific innate immune response patterns are distinctly affected by genetic diversity
(2023)
Innate immune responses vary by pathogen and host genetics. We analyze quantitative trait loci (eQTLs) and transcriptomes of monocytes from 215 individuals stimulated by fungal, Gram-negative or Gram-positive bacterial pathogens. We identify conserved monocyte responses to bacterial pathogens and a distinct antifungal response. These include 745 response eQTLs (reQTLs) and corresponding genes with pathogen-specific effects, which we find first in samples of male donors and subsequently confirm for selected reQTLs in females. reQTLs affect predominantly upregulated genes that regulate immune response via e.g., NOD-like, C-type lectin, Toll-like and complement receptor-signaling pathways. Hence, reQTLs provide a functional explanation for individual differences in innate response patterns. Our identified reQTLs are also associated with cancer, autoimmunity, inflammatory and infectious diseases as shown by external genome-wide association studies. Thus, reQTLs help to explain interindividual variation in immune response to infection and provide candidate genes for variants associated with a range of diseases.
Background
Haemophilus influenzae (Hi) is a Gram-negative bacterium that may cause sepsis or meningitis, treatment of which mainly includes β-lactam antibiotics. Since 2019 EUCAST breakpoints for piperacillin/tazobactam have been available. Little is known about the prevalence and mechanisms of piperacillin/tazobactam resistance in Hi.
Objectives
To provide reliable prevalence data for piperacillin/tazobactam resistance in Hi in Germany, to evaluate different antibiotic susceptibility testing methods and to examine possible resistance mechanisms.
Methods
According to EUCAST breakpoints, the MIC for piperacillin/tazobactam resistance is >0.25 mg/L. All invasive Hi in Germany from 2019 were examined by gradient agar diffusion (GAD) for piperacillin/tazobactam susceptibility. Piperacillin/tazobactam broth microdilution (BMD), piperacillin GAD on tazobactam-containing agar [piperacillin GAD on Mueller–Hinton agar with horse blood (MH-F)/tazobactam) and piperacillin/tazobactam agar dilution (AD) were used for confirmation. Phenotypic testing was complemented by ftsI sequencing.
Results
Piperacillin/tazobactam GAD resulted in 2.9% (21/726) resistant Hi. BMD did not confirm piperacillin/tazobactam resistance. Two strains were found resistant by AD, of which one was also resistant using piperacillin GAD on MH-F/tazobactam. Overall, we found two strains with a piperacillin/tazobactam MIC >0.25 mg/L in at least two different tests (0.3%). Both were β-lactamase-producing amoxicillin/clavulanate-resistant with PBP3 mutations characterized as group III-like+. Relevant PBP3 mutations occurred in six strains without phenotypic piperacillin/tazobactam resistance. These mutations suggest a reduced efficacy of β-lactam antibiotics in these isolates.
Conclusions
Piperacillin/tazobactam resistance prevalence in invasive Hi is low in Germany. Reduced susceptibility was correlated with PBP3 mutations, in particular with group III mutations.
Alveolar (AE) and cystic (CE) echinococcosis are two parasitic diseases caused by the tapeworms Echinococcus multilocularis and E. granulosus sensu lato (s. l.), respectively. Currently, AE and CE are mainly diagnosed by means of imaging techniques, serology, and clinical and epidemiological data. However, no viability markers that indicate parasite state during infection are available. Extracellular small RNAs (sRNAs) are short non-coding RNAs that can be secreted by cells through association with extracellular vesicles, proteins, or lipoproteins. Circulating sRNAs can show altered expression in pathological states; hence, they are intensively studied as biomarkers for several diseases. Here, we profiled the sRNA transcriptomes of AE and CE patients to identify novel biomarkers to aid in medical decisions when current diagnostic procedures are inconclusive. For this, endogenous and parasitic sRNAs were analyzed by sRNA sequencing in serum from disease negative, positive, and treated patients and patients harboring a non-parasitic lesion. Consequently, 20 differentially expressed sRNAs associated with AE, CE, and/or non-parasitic lesion were identified. Our results represent an in-depth characterization of the effect E. multilocularis and E. granulosus s. l. exert on the extracellular sRNA landscape in human infections and provide a set of novel candidate biomarkers for both AE and CE detection.
Background and Objective: Staphylococcus aureus is one of the major pathogens of nosocomial infections as wells as community-acquired (CA) infections worldwide. So far, large-scale comprehensive molecular and epidemiological characterisation of S. aureus from very diverse settings has not been carried out in India. The objective of this study is to evaluate the molecular, epidemiological and virulence characteristics of S. aureus in both community and hospital settings in Chennai, southern India. Methods: S. aureus isolates were obtained from four different groups (a) healthy individuals from closed community settings, (b) inpatients from hospitals, (c) outpatients from hospitals, representing isolates of hospital-community interface and (d) HIV-infected patients to define isolates associated with the immunocompromised. Antibiotic susceptibility testing, multiplex polymerase chain reactions for detection of virulence and resistance determinants, molecular typing including Staphylococcal cassette chromosome mec (SCCmec) and agr typing, were carried out. Sequencing-based typing was done using spa and multilocus sequence typing (MLST) methods. Clonal complexes (CC) of hospital and CA methicillin-resistant S. aureus (MRSA) were identified and compared for virulence and resistance.
Results and Conclusion: A total of 769 isolates of S. aureus isolates were studied. The prevalence of MRSA was found to be 7.17%, 81.67%, 58.33% and 22.85% for groups a, b, c and d, respectively. Of the four SCCmec types (I, III, IV and V) detected, SCCmec V was found to be predominant. Panton-Valentine leucocidin toxin genes were detected among MRSA isolates harbouring SCCmec IV and V. A total of 78 spa types were detected, t657 being the most prevalent. 13 MLST types belonging to 9 CC were detected. CC1 (ST-772, ST-1) and CC8 (ST238, ST368 and ST1208) were found to be predominant among MRSA. CA-MRSA isolates with SCCmec IV and V were isolated from all study groups including hospitalised patients and were found to be similar by molecular tools. This shows that CA MRSA has probably infiltrated into the hospital settings.
Background
Colonization with Staphylococcus aureus has been identified as a risk for subsequent occurrence of infection. This study investigated the relationship between S. aureus colonization of patients and healthcare workers (HCWs), and subsequent surgical site infections (SSI).
Methods
Between December 2014 and September 2015, a total of 930 patients and 143 HCWs were enrolled from the Bugando Medical Centre and Sekou Toure hospital in Mwanza, Tanzania. On admission and discharge nasal swabs, with an additional of wound swab for those who developed SSI were collected from patients whereas HCWs were swabbed once. Identification and antimicrobial susceptibility testing were done by VITEK-MS and VITEK-2, respectively. Detection of Panton Valentine leukocidin (PVL) and mecA genes was done by PCR. S. aureus isolates were further characterized by spa typing and Multi-Locus Sequence Typing (MLST).
Results
Among 930 patients screened for S. aureus on admission, 129 (13.9%) were positive of which 5.4% (7/129) were methicillin-resistant S. aureus (MRSA). Amongst 363 patients rescreened on discharge, 301 patients had been tested negative on admission of whom 29 (9.6%) turned positive after their hospital stay. Three (10.3%) of the 29 acquired S. aureus were MRSA. Inducible Clindamycin resistance occurred more often among acquired S. aureus isolates than among isolates from admission [34.5% (10/29) vs. 17.1% (22/129), P = 0.018]. S. aureus contributed to 21.1% (n = 12) of the 57 cases of investigated SSIs among 536 patients followed. Seven out of eight S. aureus carriage/infection pairs had the same spa and sequence types. The previously reported dominant PVL-positive ST88 MRSA strain with spa type t690 was detected in patients and HCW.
Conclusion
A significant proportion of patients acquired S. aureus during hospitalization. The finding of more than 90% of S. aureus SSI to be of endogenous source underscores the need of improving infection prevention and control measures including screening and decolonization of high risk patients.
Objectives
Mechanisms of wound healing are often impaired in patients with osteonecrosis of the jaw (ONJ). According to the guidelines for the treatment of this disease, early surgical intervention is indicated. However, surgery often faces complications such as wound healing disorders. The application of platelet-rich fibrin (PRF) after necrosectomy between bone and mucosa may constitute a promising approach to improve surgical results. An aspect that was not investigated until now is that PRF acts as a “bio-carrier” for antibiotics previously applied intravenously.
Materials and methods
We investigated the antimicrobial properties of PRF in 24 patients presenting ONJ undergoing systemic antibiosis with ampicillin/sulbactam. We measured the concentration of ampicillin/sulbactam in plasma and PRF and performed agar diffusion tests. Ampicillin/sulbactam was applied intravenously to the patient 10 minutes for blood sampling for PRF. No further incorporation of patients’ blood or PRF product with antibiotic drugs was obtained. Four healthy patients served as controls.
Results
Our results revealed that PRF is highly enriched with ampicillin/sulbactam that is released to the environment. The antibiotic concentration in PRF was comparable to the plasma concentration of ampicillin/sulbactam. The inhibition zone (IZ) of PRF was comparable to the standard ampicillin/sulbactam discs used in sensitivity testing.
Conclusions
The results of our study demonstrated that PRF is a reliable bio-carrier for systemic applied antibiotics and exhibits a large antimicrobial effect.
Clinical relevance
We describe a clinically useful feature of PRF as a bio-carrier for antibiotics. Especially when applied to poorly perfused tissues and bone such as in ONJ, the local release of antibiotics can reduce wound healing disorders like infections.
High seroprevalence of SARS-CoV-2 in Mwanza, northwestern Tanzania: a population-based survey
(2022)
The transmission of the SARS-CoV-2 virus, which causes COVID-19, has been documented worldwide. However, the evidence of the extent to which transmission has occurred in different countries is still to be established. Understanding the magnitude and distribution of SARS-CoV-2 through seroprevalence studies is important in designing control and preventive strategies in communities. This study investigated the seropositivity of the SARS-CoV-2 virus antibodies in the communities of three different districts in the Mwanza region, Tanzania. A household cross-sectional survey was conducted in September 2021 using the modified African Centre for Disease and Prevention (ACDC) survey protocol. A blood sample was obtained from one member of each of the selected households who consented to take part in the survey. Immunochromatographic rapid test kits were used to detect IgM and IgG SARS-CoV-2 antibodies, followed by descriptive data analysis. Overall, 805 participants were enrolled in the study with a median age of 35 (interquartile range (IQR):27–47) years. The overall SARS-CoV-2 seropositivity was 50.4% (95%CI: 46.9–53.8%). The IgG and IgM seropositivity of the SARS-CoV-2 antibodies was 49.3% and 7.2%, respectively, with 6.1% being both IgG and IgM seropositive. A history of runny nose (aOR: 1.84, 95%CI: 1.03–3.5, p = 0.036), loss of taste (aOR: 1.84, 95%CI: 1.12–4.48, p = 0.023), and living in Ukerewe (aOR: 3.55, 95%CI: 1.68–7.47, p = 0.001) and Magu (aOR: 2.89, 95%CI: 1.34–6.25, p= 0.007) were all independently associated with SARS-CoV-2 IgM seropositivity. Out of the studied factors, living in the Ukerewe district was independently associated with IgG seropositivity (aOR 1.29, CI 1.08–1.54, p = 0.004). Twenty months after the first case of COVID-19 in Tanzania, about half of the studied population in Mwanza was seropositive for SARS-CoV-2.
Candida auris was first described as a yeast pathogen in 2009. Since then, the species has emerged worldwide. In contrast to most other Candida spp., C. auris frequently exhibits multi-drug resistance and is readily transmitted in hospital settings. While most detections so far are from colonised patients, C. auris does cause superficial and life-threatening invasive infections. During management of the first documented C. auris transmission in a German hospital, experts from the National Reference Centers for Invasive Fungal Infections (NRZMyk) and the National Reference Center for Surveillance of Nosocomial Infections screened available literature and integrated available knowledge on infection prevention and C. auris epidemiology and biology to enable optimal containment. Relevant recommendations developed during this process are summarised in this guidance document, intended to assist in management of C. auris transmission and potential outbreak situations. Rapid and effective measures to contain C. auris spread require a multi-disciplinary approach that includes clinical specialists of the affected unit, nursing staff, hospital hygiene, diagnostic microbiology, cleaning staff, hospital management and experts in diagnostic mycology / fungal infections. Action should be initiated in a step-wise process and relevant interventions differ between management of singular C. auris colonised / infected patients and detection of potential C. auris transmission or nosocomial outbreaks.